LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 75

Search options

  1. Article ; Online: Shc and the mechanotransduction of cellular anchorage and metastasis.

    Terada, Lance S

    Small GTPases

    2017  Volume 10, Issue 1, Page(s) 64–71

    Abstract: Tissue cells continually monitor anchorage conditions by gauging the physical properties of their underlying matrix and surrounding environment. The Rho and Ras GTPases are essential components of these mechanosensory pathways. These molecular switches ... ...

    Abstract Tissue cells continually monitor anchorage conditions by gauging the physical properties of their underlying matrix and surrounding environment. The Rho and Ras GTPases are essential components of these mechanosensory pathways. These molecular switches control both cytoskeletal as well as cell fate responses to anchorage conditions and are thus critical to our understanding of how cells respond to their physical environment and, by extension, how malignant cells gainsay these regulatory pathways. Recent studies indicate that 2 proteins produced by the
    MeSH term(s) Animals ; Humans ; Mechanotransduction, Cellular ; Neoplasm Metastasis ; Neoplasms/metabolism ; Neoplasms/pathology ; Shc Signaling Adaptor Proteins/metabolism ; ras Proteins/metabolism ; rhoA GTP-Binding Protein/metabolism
    Chemical Substances Shc Signaling Adaptor Proteins ; ras Proteins (EC 3.6.5.2) ; rhoA GTP-Binding Protein (EC 3.6.5.2)
    Language English
    Publishing date 2017-02-21
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2682247-7
    ISSN 2154-1256 ; 2154-1248
    ISSN (online) 2154-1256
    ISSN 2154-1248
    DOI 10.1080/21541248.2016.1273172
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Characteristics and evaluation of acute exacerbations in chronic interstitial lung diseases.

    Kershaw, Corey D / Batra, Kiran / Torrealba, Jose R / Terada, Lance S

    Respiratory medicine

    2021  Volume 183, Page(s) 106400

    Abstract: Acute exacerbations of fibrosing interstitial lung disease (ILD) occur in both idiopathic pulmonary fibrosis (IPF) as well as non-IPF ILDs. An expert consensus definition has allowed for more frequent reporting of IPF exacerbations. The same is lacking ... ...

    Abstract Acute exacerbations of fibrosing interstitial lung disease (ILD) occur in both idiopathic pulmonary fibrosis (IPF) as well as non-IPF ILDs. An expert consensus definition has allowed for more frequent reporting of IPF exacerbations. The same is lacking for non-IPF ILD exacerbations. The incidence of non-IPF ILD exacerbations is likely less than in IPF, but the two entities share similar risk factors, such as increased frequency as physiologic derangements advance. The radiologic and histopathologic spectrum of acute ILD exacerbations extends from organizing pneumonia (OP) to the more treatment-refractory diffuse alveolar damage (DAD) pattern. Indeed, responsiveness to various therapies may depend on the relative components of these entities, favoring OP over DAD. There are no proven therapies for acute ILD exacerbations. Corticosteroids are a mainstay in any regimen although clear evidence of benefit does not exist. A variety of immunosuppressant agents have purported success in historical cohort studies - cyclophosphamide, cyclosporine A, and tacrolimus most commonly. Only one randomized controlled trial has been published, studying recombinant thrombomodulin for IPF exacerbation, but the primary outcome of survivor proportion at 90 days was not met. Other novel therapies for ILD exacerbations are still under investigation. The short and long-term prognosis of acute exacerbations of ILD is poor, especially in patients with IPF. Transplant referral should be considered early for both IPF as well as fibrosing non-IPF ILDs, given the unpredictability of the exacerbation event.
    MeSH term(s) Adrenal Cortex Hormones/therapeutic use ; Aged ; Chronic Disease ; Disease Progression ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Incidence ; Lung Diseases, Interstitial/diagnostic imaging ; Lung Diseases, Interstitial/drug therapy ; Lung Diseases, Interstitial/epidemiology ; Lung Diseases, Interstitial/pathology ; Male ; Middle Aged ; Prognosis ; Risk Factors
    Chemical Substances Adrenal Cortex Hormones ; Immunosuppressive Agents
    Language English
    Publishing date 2021-04-26
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1003348-8
    ISSN 1532-3064 ; 0954-6111
    ISSN (online) 1532-3064
    ISSN 0954-6111
    DOI 10.1016/j.rmed.2021.106400
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: ROS signaling and ER stress in cardiovascular disease.

    Ochoa, Cristhiaan D / Wu, Ru Feng / Terada, Lance S

    Molecular aspects of medicine

    2018  Volume 63, Page(s) 18–29

    Abstract: The endoplasmic reticulum (ER) produces the vast majority of all proteins secreted into the extracellular space, including hormones and cytokines, as well as cell surface receptors and other proteins which interact with the environment. Accordingly, this ...

    Abstract The endoplasmic reticulum (ER) produces the vast majority of all proteins secreted into the extracellular space, including hormones and cytokines, as well as cell surface receptors and other proteins which interact with the environment. Accordingly, this organelle controls essentially all vital links to a cell's external milieu, responding to systemic metabolic, inflammatory, endocrine, and mechanical stimuli. The central role the ER plays in meeting protein synthetic and quality control requirements in the face of such demands is matched by an extensive and versatile ER stress response signaling network. ROS mediate several critical aspects of this response. Nox4, an ER resident capable of producing ROS, acts as a proximal signaling intermediate to transduce ER stress-related conditions to the unfolded protein response, a homeostatic corrective mechanism. However, chronic ER stress caused by unrelenting internal or external demands produces a secondary rise in ROS, generally resulting in cell death. Sorting out the involvement of ROS at different levels of the ER stress response in specific cell types is key to understanding the molecular basis for chronic diseases such as atherosclerosis, hypertension, and diabetes. Here, we provide an overview of ER stress signaling with an emphasis on the role of ROS.
    MeSH term(s) Animals ; Autophagy ; Biomarkers ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/metabolism ; Endoplasmic Reticulum/metabolism ; Endoplasmic Reticulum Stress ; Humans ; Reactive Oxygen Species/metabolism ; Signal Transduction ; Unfolded Protein Response
    Chemical Substances Biomarkers ; Reactive Oxygen Species
    Language English
    Publishing date 2018-03-22
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S. ; Review
    ZDB-ID 197640-0
    ISSN 1872-9452 ; 0098-2997
    ISSN (online) 1872-9452
    ISSN 0098-2997
    DOI 10.1016/j.mam.2018.03.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: High-dose Mycophenolate Use at Vaccination Is Independently Associated With Breakthrough COVID-19 Among Lung Transplant Patients.

    Joerns, John / Bollineni, Srinivas / Mahan, Luke D / Mohanka, Manish R / Lawrence, Adrian / Timofte, Irina / Torres, Fernando / La Hoz, Ricardo M / Zhang, Song / Kershaw, Corey D / Kaza, Vaidehi / Terada, Lance S / Banga, Amit

    Transplantation

    2022  Volume 106, Issue 5, Page(s) e271–e274

    MeSH term(s) COVID-19/prevention & control ; Humans ; Immunosuppressive Agents/adverse effects ; Lung Transplantation/adverse effects ; SARS-CoV-2 ; Vaccination
    Chemical Substances Immunosuppressive Agents
    Language English
    Publishing date 2022-03-01
    Publishing country United States
    Document type Letter
    ZDB-ID 208424-7
    ISSN 1534-6080 ; 0041-1337
    ISSN (online) 1534-6080
    ISSN 0041-1337
    DOI 10.1097/TP.0000000000004089
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Aiolos and Lymphocyte Mimicry in Lung Cancer.

    Terada, Lance S / Liu, Zhe

    Molecular & cellular oncology

    2014  Volume 1, Issue 1, Page(s) e29912

    Abstract: Aggressive carcinomas tend to adopt behaviors normally restricted to lymphocytes, including anchorage-independent mobilization, response to chemokines, and modulation of local inflammatory conditions. In a recent study we identified the lymphocyte- ... ...

    Abstract Aggressive carcinomas tend to adopt behaviors normally restricted to lymphocytes, including anchorage-independent mobilization, response to chemokines, and modulation of local inflammatory conditions. In a recent study we identified the lymphocyte-restricted chromatin regulator Aiolos as an epigenetic driver of lymphocyte mimicry in lung cancer that links immune cell development to metastatic behavior.
    Language English
    Publishing date 2014-07-28
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2372-3556
    ISSN 2372-3556
    DOI 10.4161/mco.29912
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: What underlies endothelial shear sensing? The matrix, of course.

    Terada, Lance S

    Circulation research

    2008  Volume 103, Issue 6, Page(s) 562–564

    MeSH term(s) Animals ; Endothelium, Vascular/anatomy & histology ; Endothelium, Vascular/physiology ; Extracellular Matrix Proteins/chemistry ; Extracellular Matrix Proteins/physiology ; Humans ; Integrins/chemistry ; Integrins/physiology ; Shear Strength
    Chemical Substances Extracellular Matrix Proteins ; Integrins
    Language English
    Publishing date 2008-09-16
    Publishing country United States
    Document type Comment ; Editorial ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 80100-8
    ISSN 1524-4571 ; 0009-7330 ; 0931-6876
    ISSN (online) 1524-4571
    ISSN 0009-7330 ; 0931-6876
    DOI 10.1161/CIRCRESAHA.108.184382
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A Case Report of Breakthrough Infections With 2 SARS-CoV-2 Variants in a Lung Transplant Patient.

    Mahan, Luke D / Mohanka, Manish R / Joerns, John / Lawrence, Adrian / Bollineni, Srinivas / Kaza, Vaidehi / Timofte, Irina / La Hoz, Ricardo M / Sorelle, Jeffrey / Terada, Lance S / Kershaw, Corey D / Torres, Fernando / Banga, Amit

    Transplantation proceedings

    2022  

    Abstract: A lung transplant (LT) patient developed 2 distinct episodes of COVID-19, confirmed by whole-genome sequencing, which was caused by the Delta, and then followed 6 weeks later, by the Omicron variant. The clinical course with Omicron was more severe, ... ...

    Abstract A lung transplant (LT) patient developed 2 distinct episodes of COVID-19, confirmed by whole-genome sequencing, which was caused by the Delta, and then followed 6 weeks later, by the Omicron variant. The clinical course with Omicron was more severe, leading us to speculate that Omicron may not be any milder among LT patients. We discuss the potential mechanisms behind the Omicron not being any milder among LT patients and emphasize the need for outcomes data among these patients. Until such data become available, it may be prudent to maintain clinical equipoise as regards the relative virulence of the newer variants among LT patients.
    Language English
    Publishing date 2022-07-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 82046-5
    ISSN 1873-2623 ; 0041-1345
    ISSN (online) 1873-2623
    ISSN 0041-1345
    DOI 10.1016/j.transproceed.2022.07.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Characteristics and outcomes among vaccinated lung transplant patients with breakthrough COVID-19.

    Bollineni, Srinivas / Mahan, Luke D / Duncan, Patrick / Mohanka, Manish R / Lawrence, Adrian / Joerns, John / Timofte, Irina / Torres, Fernando / La Hoz, Ricardo M / Kershaw, Corey D / Terada, Lance S / Kaza, Vaidehi / Banga, Amit

    Transplant infectious disease : an official journal of the Transplantation Society

    2022  Volume 24, Issue 2, Page(s) e13784

    Abstract: Background: Despite multiple studies evaluating the immunological responsiveness to vaccines, the clinical effectiveness of the two-dose mRNA vaccine schedule among lung transplant (LT) patients has not been evaluated.: Methods: We included LT ... ...

    Abstract Background: Despite multiple studies evaluating the immunological responsiveness to vaccines, the clinical effectiveness of the two-dose mRNA vaccine schedule among lung transplant (LT) patients has not been evaluated.
    Methods: We included LT patients who tested positive for SARS-CoV-2 on a nasopharyngeal swab between March 1, 2020, and August 25, 2021 (n = 70). The study group was divided based on their vaccination status.
    Results: During the study period, 14 fully vaccinated LT patients with one of the mRNA vaccines tested positive for COVID-19 (median age 54, range 30-62 years, M:F 9:5). The vaccinated cohort was younger with bilateral LT, have suppurative conditions as the transplant indication, and present with milder symptoms. However, pulmonary parenchymal involvement was seen among all 12 patients where computed tomography (CT) of chest was available. The laboratory profile indicated a more subdued inflammatory response among the vaccinated group. A lower proportion of vaccinated patients developed respiratory failure, needed ICU admission or ventilator support, although none of the differences achieved statistical significance. None of the vaccinated patients succumbed to COVID-19 during the study period, while the 4-week mortality among unvaccinated patients was nearly 15% (8/56).
    Conclusions: In this cohort of vaccinated LT patients who developed breakthrough COVID-19, the clinical course, risk of complications, and outcomes trended better than unvaccinated patients. However, universal involvement of the allograft demonstrates the continued vulnerability of these patients to significant sequelae from COVID-19. Future studies may evaluate the incremental protection of vaccination after the completion of the third dose of mRNA vaccines among LT patients.
    MeSH term(s) Adult ; COVID-19/prevention & control ; Humans ; Lung Transplantation/adverse effects ; Middle Aged ; SARS-CoV-2 ; Vaccination ; Vaccines, Synthetic ; mRNA Vaccines
    Chemical Substances Vaccines, Synthetic ; mRNA Vaccines
    Language English
    Publishing date 2022-01-19
    Publishing country Denmark
    Document type Journal Article
    ZDB-ID 1476094-0
    ISSN 1399-3062 ; 1398-2273
    ISSN (online) 1399-3062
    ISSN 1398-2273
    DOI 10.1111/tid.13784
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Specificity in reactive oxidant signaling: think globally, act locally.

    Terada, Lance S

    The Journal of cell biology

    2006  Volume 174, Issue 5, Page(s) 615–623

    Abstract: Although reactive oxidants have long been stigmatized as unwanted metabolic byproducts, the expression of oxidases specifically functioning to produce these same molecules in a regulated fashion is surprisingly pervasive throughout metazoan and plant ... ...

    Abstract Although reactive oxidants have long been stigmatized as unwanted metabolic byproducts, the expression of oxidases specifically functioning to produce these same molecules in a regulated fashion is surprisingly pervasive throughout metazoan and plant evolution. Although the involvement of oxidants in many signaling pathways is well documented, the cellular strategies for conferring pathway specificity to such reactive molecules have remained more recondite. Recent studies now suggest that cells may spatially restrict oxidant production to allow microdomain-specific signaling.
    MeSH term(s) Animals ; Calcium Signaling ; Cytosol/metabolism ; Evolution, Molecular ; Homeostasis ; Humans ; Mitochondria/metabolism ; NADPH Oxidases/genetics ; NADPH Oxidases/metabolism ; Oxidative Stress ; Reactive Oxygen Species/metabolism ; Signal Transduction ; Tyrosine/metabolism ; rac1 GTP-Binding Protein/metabolism
    Chemical Substances Reactive Oxygen Species ; Tyrosine (42HK56048U) ; NADPH Oxidases (EC 1.6.3.-) ; neutrophil cytosolic factor 1 (EC 1.6.3.1) ; rac1 GTP-Binding Protein (EC 3.6.5.2)
    Language English
    Publishing date 2006-08-28
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S. ; Review
    ZDB-ID 218154-x
    ISSN 1540-8140 ; 0021-9525
    ISSN (online) 1540-8140
    ISSN 0021-9525
    DOI 10.1083/jcb.200605036
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: ECMO Long Haulers: A Distinct Phenotype of COVID-19-Associated ARDS With Implications for Lung Transplant Candidacy.

    Mohanka, Manish R / Joerns, John / Lawrence, Adrian / Bollineni, Srinivas / Kaza, Vaidehi / Cheruku, Sreekanth / Leveno, Matthew / Chen, Catherine / Terada, Lance S / Kershaw, Corey D / Torres, Fernando / Peltz, Matthias / Wait, Michael A / Hackmann, Amy E / Banga, Amit

    Transplantation

    2022  Volume 106, Issue 4, Page(s) e202–e211

    Abstract: Background: Studies indicate that the recovery from coronavirus disease 2019 (COVID-19)-associated acute respiratory distress syndrome may be slower than other viral pneumonia. There are limited data to guide decisions among patients who need ... ...

    Abstract Background: Studies indicate that the recovery from coronavirus disease 2019 (COVID-19)-associated acute respiratory distress syndrome may be slower than other viral pneumonia. There are limited data to guide decisions among patients who need extracorporeal membrane oxygenation (ECMO) support, especially the expected time of recovery and considering lung transplantation (LT).
    Methods: This was a retrospective chart review of patients with COVID-19-associated acute respiratory distress syndrome placed on ECMO between March 1, 2020, and September 15, 2021 (n = 20; median age, 44 y; range, 22-62 y; male:female, 15:5). We contrasted the baseline variables and clinical course of patients with and without the need for ECMO support >30 d (ECMO long haulers, n = 10).
    Results: Ten patients met the criteria for ECMO long haulers (median duration of ECMO, 86 d; range, 42-201 d). The long haulers were healthier at baseline with fewer comorbidities but had worse pulmonary compliance and higher partial pressure of CO2. They had a significantly higher number of membrane oxygenator failures, changes to their cannulation sites, and suffer more complications on ECMO. One of the long hauler was bridged to LT while another 6 patients recovered and were discharged. Overall survival was better among the ECMO long haulers (70% versus 20%; 9.3, 1.2-73; P = 0.03).
    Conclusions: Despite worse pulmonary physiology, frequent complications, and a tortuous hospital course that may appear to portend a poor prognosis, ECMO long haulers have the potential to recover and be weaned off ECMO without the need for LT. A customized approach comprising a more conservative timeline for the consideration of LT may be prudent among these patients.
    MeSH term(s) Adult ; COVID-19/complications ; Extracorporeal Membrane Oxygenation/adverse effects ; Female ; Humans ; Lung Transplantation ; Male ; Middle Aged ; Phenotype ; Respiratory Distress Syndrome/etiology ; Respiratory Distress Syndrome/therapy ; Retrospective Studies ; Young Adult
    Language English
    Publishing date 2022-01-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 208424-7
    ISSN 1534-6080 ; 0041-1337
    ISSN (online) 1534-6080
    ISSN 0041-1337
    DOI 10.1097/TP.0000000000004052
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top